By Cycle type (Fresh IVF cycles, Thawed IVF cycles, Donor Egg IVF cycles), By Procedure (Intra Cytoplasmic sperm Injection (ICSI), Pre Implantation Genetic Diagnosis (PGD), Frozen embryo Transfer/Replacement (FET/FER), Others), By End-User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Cryobanks), By Product Type (Devices, Reagents, Pharmaceuticals, Services), By Country (China, India, Japan, South Korea, Australia, Singapore), By Company
Asia-Pacific In-Vitro Fertilization Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Asia-Pacific In-Vitro Fertilization market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
In-vitro fertilization involves fertilization (IVF) of ovum using laboratory settings by implantations of egg in the ovary. Reasons for the growth of in-vitro fertilization are the presence of a large number of fertility clinics coupled with mushrooming surrogacy among women. Other factors catalyzing the growth of in-vitro fertilization during the forecast period are the emerging rate of the polycystic ovarian syndrome (PCOS) and the development of assisted reproductive technology (ART).
According to MarkNtel Advisors’ research report “Asia-Pacific In-Vitro Fertilization Market Analysis, 2020”, the Asia-Pacific In-Vitro Fertilization market is anticipated to grow at a CAGR of around 11.35% during 2020-25.
Fertility Clinics are Witnessing an Exponential Growth
In 2019, fertility clinics and hospitals had collectively contributed about 80% of the Asia-Pacific IVF market share, on an account of their sophisticated and highly advanced treatments. Moreover, fertility clinics are surging in number with increasing number of patients. Thus, the fertility clinic segment is witnessing an amplified demand in recent times and is expected to gain momentum during 2020-25.
Fresh IVF Cycles Segment Bagged the Substantial Market Share
The fresh IVF cycles (non-donor) segment is currently the largest segment, accounting for more than three-fifths of the total market in 2020. As the fresh embryo IVF cycle begins with the ovarian stimulation, which is followed by the recovery of all eggs from the patient, the eggs are inserted for the creation of an embryo and are then transferred back in the patient. The remaining eggs are used as future frozen IVF cycles as stated in the MarkNtel Advisors’ research report “Asia-Pacific In-Vitro Fertilization Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Asia-Pacific In-Vitro Fertilization market include Adorefem Gynec Pro-Infertility Division, Cook Medical, Esco Group of Companies, Fujifilm Irvine, Ferring Pharmaceuticals, IVFtech ApS, Merck KGaA, Thermofisher Scientific, Olympus Corporation, VitroLife AB, etc.
Key Questions Answered in the Market Research Report
What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast Numbers, Market Segmentation, Market Shares) of Asia-Pacific In-Vitro Fertilization Market?
What are the region wise industry size, growth drivers and challenges key market trends?
What are the key innovations, technology upgrades, opportunities, regulations in the Asia-Pacific In-Vitro Fertilization Market?
Who are the key competitors or market players and how they perform in Asia-Pacific In-Vitro Fertilization Market on the basis of competitive benchmarking matrix?
What are the key results derived from the market surveys conducted during the course of Asia-Pacific In-Vitro Fertilization Market study?
Q. What is the historical year, base year, and forecast year considered in the research report on Asia-Pacific In-Vitro Fertilization Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million,
Q. What would be the growth rate or CAGR of the Asia-Pacific In-Vitro Fertilization Market during 2020-25?
A. The growth rate of the Asia-Pacific In-Vitro Fertilization Market during 2020-25 is forecast to be around 11.35%.
Q. Who are the key competitors or players operating in Asia-Pacific In-Vitro Fertilization Market?
A. Adorefem Gynec Pro-Infertility Division, Cook Medical, Esco Group of Companies, Fujifilm Irvine, Ferring Pharmaceuticals, IVFtech ApS, Merck KGaA, Thermofisher Scientific, Olympus Corporation, VitroLife AB, etc are few of the leading players in the Asia-Pacific In-Vitro Fertilization Market.
Q. Which cycle type segment would emerge as an opportunity area for players in Asia-Pacific In-Vitro Fertilization Market?
A. The fresh cycle type segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which countries would emerge as an opportunity area for players in Asia-Pacific In-Vitro Fertilization Market?
A. China, India, and Japan are grabbing a significant market share continues to grow at the highest CAGR, presenting immense opportunities for manufacturers and suppliers of the Asia-Pacific In-Vitro Fertilization Market.
Expert Verbatim- Interview Excerpts of 10 industry experts
Additional IVF Procedures
Legal Requirements and Framework at Regional Level